State Street’s MediWound MDWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.48M Buy
168,669
+24,899
+17% +$395K ﹤0.01% 3270
2026
Q1
$2.32M Buy
143,770
+19,260
+15% +$335K ﹤0.01% 3258
2025
Q4
$2.3M Buy
124,510
+12,066
+11% +$220K ﹤0.01% 3296
2025
Q3
$2.03M Buy
112,444
+1,601
+1% +$29.5K ﹤0.01% 3335
2025
Q2
$2.15M Buy
110,843
+38,748
+54% +$730K ﹤0.01% 3293
2025
Q1
$1.12M Buy
72,095
+4,337
+6% +$77.6K ﹤0.01% 3403
2024
Q4
$1.21M Buy
67,758
+1,500
+2% +$25.9K ﹤0.01% 3448
2024
Q3
$1.2M Buy
66,258
+45,529
+220% +$831K ﹤0.01% 3454
2024
Q2
$322K Buy
+20,729
New +$343K ﹤0.01% 3674

Other funds holding MDWD

State Street's MDWD Position: Q2 2026 in Review

State Street increased its MediWound (MDWD) stake by 17% in Q2 2026, buying an estimated $395K and bringing the position to 168,669 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #3270.

State Street first reported a position in MDWD in Q2 2024 and has held it in 9 quarters since. 79 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

  • State Street held 168,669 shares of MediWound worth $2.48M as of Q2 2026.
  • State Street bought 24,899 MediWound shares in Q2 2026, an estimated $395K.
  • MediWound made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3270 holding.
  • State Street first reported a position in MediWound in Q2 2024 and has held it in 9 quarters since.
  • 79 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.